Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.

@article{Kortekaas2010RiftVF,
  title={Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.},
  author={Jeroen Kortekaas and S M de Boer and Jet Kant and Rianka P. M. Vloet and Adriaan F. G. Antonis and Rob J. M. Moormann},
  journal={Vaccine},
  year={2010},
  volume={28 27},
  pages={4394-401}
}
Rift Valley fever virus (RVFV) causes recurrent large outbreaks among humans and livestock. Although the virus is currently confined to the African continent and the Arabian Peninsula, there is a growing concern for RVFV incursions into countries with immunologically naïve populations. The RVFV structural glycoproteins Gn and Gc are preferred targets in the development of subunit vaccines that can be used to control future outbreaks. We here report the production of Gn and Gc by a recombinant… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

Similar Papers

Loading similar papers…